Monthly Archives: January 2017

IMPORTANT AGRX INVESTOR DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 27, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Agile Therapeutics, Inc. (“Agile” or the “Company”) (NASDAQ: AGRX). Investors, who purchased or otherwise acquired shares between March 9, 2016 and January 3, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 7, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Agile is a pharmaceutical company that makes and sells prescription female contraceptive products.

On January 3, 2017, Agile revealed new information related to its Phase 3 SECURE study assessing Agile’s combined hormonal contraceptive patch product, Twirla. The FDA wanted the study after it rejected Agile’s initial marketing application in 2013.

The Company stated that 2% of study participants suffered “serious adverse events” including “deep vein thrombosis, pulmonary embolism, gallbladder disease, ectopic pregnancy, and depression.” Furthermore, 51.4% of subjects left the study.

When this information was revealed to the public, the value of Agile stock fell almost 64%, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

https://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 453723

BRK Inc. (OTC: BRKK) iSee Sports RefCAM to Broadcast NHL All-Star Game From Staples Center, Los Angeles, January 29, 2017

LAS VEGAS, NV / ACCESSWIRE / January 27, 2017 / BRK, Inc. (OTC PINK: BRKK), is pleased to announce that RefCAM will be used to broadcast portions of the NHL All-Star game this weekend, to be televised on Sunday, January 29, 2017 from Staples Center in Los Angeles, CA at 12:30 p.m. PST.

“We urge all RefCAM fans to tune in to the game and support RefCAM,” stated Brian Keasberry, CEO of BRK Inc.

Further details on the game, and tickets are available at https://www.nhl.com/kings/tickets/2017-all-star-game

BRK Inc. invites fans to sign up for advance notice of games featuring the RefCAM at www.brkincorporated.com. Regular updates are also available at www.iseesports.pro.

About BRK, Inc.

BRK Inc. (OTC PINK: BRKK), established in 2008, is owner of the Helmet Camera patents that make the RefCam possible. With the acquisition of the live broadcast helmet camera patent, BRK is poised to enter sports marketing in a big way. iSee Sports Inc. is a wholly owned subsidiary of BRK, Inc.

The foregoing contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are intended to be covered by the safe harbor provisions of the federal securities laws. Forward-looking statements often contain words such as “will,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” “is targeting,” “may,” “should,” “poised,” and other similar words or expressions. Forward-looking statements are made based upon management’s current expectations and beliefs and are not guarantees of future performance. Our actual business, financial condition or results of operations may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties which include, among others, those described in any of our other filings with the SEC. In addition, such statements could be affected by risks and uncertainties related to: (i) commercialization of our newly-acquired helmet camera, (ii) continuing development and protection of our intellectual property, (iii) unexpected industry competition, (iv) the need to raise capital to meet business requirements,
and (v) our ability to sell our products in order to generate revenues.
Forward-Looking Statements are pertinent only as of the date on which they are made, and the company undertakes no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future developments or otherwise. Any future public statements or disclosures modifying any of the forward-looking statements contained in or accompanying this news release, will be deemed to supersede such statements in this news
release.
Information on BRK Inc.’s websites, www.brkincorporated.com
and www.iseesports.pro do not constitute a part of this release.

Contact:

Brian Keasberry
Tel: 1.855.702.8275
shareholder@brkincorporated.com

SOURCE: BRK, Inc.

ReleaseID: 453709

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing In Rent-A-Center, Inc. to Contact the Firm Before Lead Plaintiff Deadline

NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Rent-A-Center, Inc. (“Rent-A-Center” or the “Company”) (NASDAQ: RCII) of the February 21, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on behalf of all those who purchased Rent-A-Center securities between July 27, 2015 and October 10, 2016 (the “Class Period”). The case, Hall v. Rent-A-Center, Inc. et al, No. 4:16-cv-00978, was filed on December 23, 2016, and has been assigned to Judge Amos Louis Mazzant III.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making materially false and/or misleading statements, as well as failed to disclose: (1) that the Company could not properly implement its new point of sale system (“POS”); (2) that the POS was performing extremely poorly; (3) that as a result, the Company’s Acceptance Now credit system could not be correctly implemented; (4) that the Company could not meet revenue and profitability guidance, and would need to revise its prior guidance; and (5), as a result, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

Specifically, on October 11, 2016, the Company issued a press release announcing dismal financial results for third quarter 2016. Therein, the Company disclosed that it “estimates Core U.S. same store sales for the three months ended September 30, 2016 to be down approximately 12%, and Acceptance Now same store sales to be essentially flat.” In addition, the Company announced the aforementioned issues regarding its implementation of the new POS.

On this news, Rent-A-Center’s share price fell from $12.88 per share on October 10, 2016 to a closing price of $9.18 on October 11, 2016 – a $3.70 or a 28.73% drop.

Request more information now by clicking here: www.faruqilaw.com/RCII. There is no cost or obligation to you.

Take Action

If you invested in Rent-A-Center stock or options between July 27, 2015 and October 10, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/RCII. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330, or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Rent-A-Center’s conduct to contact the firm, including whistleblowers, former employees, shareholders, and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 100170
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 453710

Organic Food Market 2017 Global Analysis, Opportunities and Forecast To 2021

focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Pune, India – January 27, 2017 /MarketersMedia/

Organic Food Industry

Description

Wiseguyreports.Com Adds “Organic Food -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

This report studies sales (consumption) of Organic Food in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Conscious Food
Organic India
Morarka Organic Foods
Ecofarms(India)
Gayatri Organic Foods
Sresta Natural Bioproducts
Navdanya Foods
Suminter India Organics
Fabindia Overseas
Pristine Organics

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/909014-global-organic-food-sales-market-report-2017

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Organic Food in these regions, from 2011 to 2021 (forecast), like

United States
China
Europe
Japan
Southeast Asia
India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Organic Milk Food
Organic Meat Food
Organic Vegetable Food
Organic Fruit Food

Split by applications, this report focuses on sales, market share and growth rate of Organic Food in each application, can be divided into
Food Industry
Pharmaceutical Intermediates

Leave a Query @ https://www.wiseguyreports.com/enquiry/909014-global-organic-food-sales-market-report-2017

Table of Contents

Global Organic Food Sales Market Report 2017
1 Organic Food Overview
1.1 Product Overview and Scope of Organic Food
1.2 Classification of Organic Food
1.2.1 Organic Milk Food
1.2.2 Organic Meat Food
1.2.3 Organic Vegetable Food
1.2.4 Organic Fruit Food
1.3 Application of Organic Food
1.3.1 Food Industry
1.3.2 Pharmaceutical Intermediates
1.4 Organic Food Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Organic Food (2012-2022)
1.5.1 Global Organic Food Sales and Growth Rate (2012-2022)
1.5.2 Global Organic Food Revenue and Growth Rate (2012-2022)

9 Global Organic Food Manufacturers Analysis
9.1 Conscious Food
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Organic Food Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Conscious Food Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Organic India
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Organic Food Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Organic India Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Morarka Organic Foods
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Organic Food Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Morarka Organic Foods Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Ecofarms(India)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Organic Food Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Ecofarms(India) Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Gayatri Organic Foods
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Organic Food Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Gayatri Organic Foods Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Sresta Natural Bioproducts
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Organic Food Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Sresta Natural Bioproducts Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Navdanya Foods
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Organic Food Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Navdanya Foods Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Suminter India Organics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Organic Food Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Suminter India Organics Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Fabindia Overseas
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Organic Food Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Fabindia Overseas Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Pristine Organics
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Organic Food Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Pristine Organics Organic Food Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=909014
Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Contact Info:
Name: NORAH TRENT
Email: Sales@Wiseguyreports.Com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Pune 411028 , Maharashtra, India
Phone: +1-646-845-9349 / +44 208 133 9349

Source URL: http://marketersmedia.com/organic-food-market-2017-global-analysis-opportunities-and-forecast-to-2021/165059

For more information, please visit https://www.wiseguyreports.com/sample-request/909014-global-organic-food-sales-market-report-2017

Source: MarketersMedia

Release ID: 165059

CRUCIAL INVESTOR ALERT: Lundin Law PC Announces an Investigation of Zagg Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 27, 2017 / Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Zagg Inc. (“Zagg” or the “Company”) (NASDAQ: ZAGG) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at brian@lundinlawpc.com.

The investigation concerns ZAGG’s subsidiary company, mophie inc. (“mophie”), falsifying inventory and sales return reserves in violation of Generally Accepted Accounting Principles; and, if ZAGG falsified mophie’s working capital during the Class Period.

On November 1, 2016, upon announcing its 2016 third quarter financial results, the Company reported a non-cash net mophie impairment charge of $24.3 million “related to disputes in acquisition-date value of working capital.” When this information was released to the investing public, shares of ZAGG fell 13.2%, to close at $5.90 per share on November 2, 2016, causing investors serious harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 453704

Telemedicine Cart Market Segmentation,Parameters and Prospects 2017 to 2022 Market Research Report

WiseGuyReports.Com Publish a New Market Research Report On – “Telemedicine Cart Market Segmentation,Parameters and Prospects 2017 to 2022 Market Research Report”.

Pune, India – January 27, 2017 /MarketersMedia/

This report studies sales (consumption) of Telemedicine Cart in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Rubbermaid Medical Solutions
Telemedicine Australia
GlobalMed
Afc Industries
AVTEQ
MEYTEC
Cisco Systems
Avizia
Vecna Technologies
HOPI SARL
LM Realisations
S-CAPE
AFHCAN
Cura Carts
Lifebot
Polycom
ICUcare
Enovate

Download Sample Report @ https://www.wiseguyreports.com/sample-request/906208-global-telemedicine-cart-sales-market-report-2017

For more information or any query mail at sales@wiseguyreports.com

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Telemedicine Cart in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Dual Display Medical Cart
Single Display Medical Cart

Split by applications, this report focuses on sales, market share and growth rate of Telemedicine Cart in each application, can be divided into
Clinic & Hospitals
Field Medical Training
Earthquake Relief
Other Inconvenient Cases

Complete Report Details @ https://www.wiseguyreports.com/reports/906208-global-telemedicine-cart-sales-market-report-2017

Table Of Contents – Major Key Points

Global Telemedicine Cart Sales Market Report 2017
1 Telemedicine Cart Overview
1.1 Product Overview and Scope of Telemedicine Cart
1.2 Classification of Telemedicine Cart
1.2.1 Dual Display Medical Cart
1.2.2 Single Display Medical Cart
1.3 Application of Telemedicine Cart
1.3.1 Clinic & Hospitals
1.3.2 Field Medical Training
1.3.3 Earthquake Relief
1.3.4 Other Inconvenient Cases
1.4 Telemedicine Cart Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Telemedicine Cart (2011-2021)
1.5.1 Global Telemedicine Cart Sales and Growth Rate (2011-2021)
1.5.2 Global Telemedicine Cart Revenue and Growth Rate (2011-2021)

2 Global Telemedicine Cart Competition by Manufacturers, Type and Application
2.1 Global Telemedicine Cart Market Competition by Manufacturers
2.1.1 Global Telemedicine Cart Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Telemedicine Cart Revenue and Share by Manufacturers (2011-2016)
2.2 Global Telemedicine Cart (Volume and Value) by Type
2.2.1 Global Telemedicine Cart Sales and Market Share by Type (2011-2016)
2.2.2 Global Telemedicine Cart Revenue and Market Share by Type (2011-2016)
2.3 Global Telemedicine Cart (Volume and Value) by Regions
2.3.1 Global Telemedicine Cart Sales and Market Share by Regions (2011-2016)
2.3.2 Global Telemedicine Cart Revenue and Market Share by Regions (2011-2016)
2.4 Global Telemedicine Cart (Volume) by Application

………..

9 Global Telemedicine Cart Manufacturers Analysis
9.1 Rubbermaid Medical Solutions
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Telemedicine Cart Product Type, Application and Specification
9.1.2.1 Dual Display Medical Cart
9.1.2.2 Single Display Medical Cart
9.1.3 Rubbermaid Medical Solutions Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Telemedicine Australia
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Telemedicine Cart Product Type, Application and Specification
9.2.2.1 Dual Display Medical Cart
9.2.2.2 Single Display Medical Cart
9.2.3 Telemedicine Australia Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 GlobalMed
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Telemedicine Cart Product Type, Application and Specification
9.3.2.1 Dual Display Medical Cart
9.3.2.2 Single Display Medical Cart
9.3.3 GlobalMed Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Afc Industries
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Telemedicine Cart Product Type, Application and Specification
9.4.2.1 Dual Display Medical Cart
9.4.2.2 Single Display Medical Cart
9.4.3 Afc Industries Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 AVTEQ
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Telemedicine Cart Product Type, Application and Specification
9.5.2.1 Dual Display Medical Cart
9.5.2.2 Single Display Medical Cart
9.5.3 AVTEQ Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 MEYTEC
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Telemedicine Cart Product Type, Application and Specification
9.6.2.1 Dual Display Medical Cart
9.6.2.2 Single Display Medical Cart
9.6.3 MEYTEC Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Cisco Systems
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Telemedicine Cart Product Type, Application and Specification
9.7.2.1 Dual Display Medical Cart
9.7.2.2 Single Display Medical Cart
9.7.3 Cisco Systems Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Avizia
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Telemedicine Cart Product Type, Application and Specification
9.8.2.1 Dual Display Medical Cart
9.8.2.2 Single Display Medical Cart
9.8.3 Avizia Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Vecna Technologies
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Telemedicine Cart Product Type, Application and Specification
9.9.2.1 Dual Display Medical Cart
9.9.2.2 Single Display Medical Cart
9.9.3 Vecna Technologies Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 HOPI SARL
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Telemedicine Cart Product Type, Application and Specification
9.10.2.1 Dual Display Medical Cart
9.10.2.2 Single Display Medical Cart
9.10.3 HOPI SARL Telemedicine Cart Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 LM Realisations
9.12 S-CAPE
9.13 AFHCAN
9.14 Cura Carts
9.15 Lifebot
9.16 Polycom
9.17 ICUcare
9.18 Enovate

………..CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=906208

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/telemedicine-cart-market-segmentationparameters-and-prospects-2017-to-2022-market-research-report/165049

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165049

Telecom Cloud Market is Growing with a CAGR of 20% and Reach USD 29 Billion by 2022

Global Telecom Cloud Market, by Services (Communication as a Service, Network as a Service), by Applications (Billing, Customer Management, Provisioning & Traffic Management), by Cloud Platform (SaaS, PaaS, IaaS) – Forecast 2022

Pune, India – January 27, 2017 /MarketersMedia/

Market Highlights
Telecom cloud Market is expected to grow with a CAGR of ~20% during the forecast period and expected to reach market size of USD ~29 Billion by the end of forecast period. Telecom cloud market is growing owing to the deployment of private networks, which are controlled and maintained by the telecommunication operators themselves, by co-location services providers, and to some extent, by their hardware and software providers. Telecom cloud is driving the benefits of cloud computing’s high availability, geographical distribution, and ease of usage. The Telecom Cloud Market is further driven by the increased need of organizations for easy to implement and cost effective cloud based solutions and services. The increasing awareness about the telecom cloud in all organizations is supporting in the growth of this market.

The migration of telecom operators to cloud is reducing their concern over hardware & network maintenance by endorsing it to the cloud computing providers to supply highly available and consistent services and to fulfill the telecommunication services requirements. The market is further driven by the rising virtualization technique which provides easy & rapidly changing cloud network topology which facilitates the user in removing of machines based services.

Market Players
• AT&T Inc. (U.S.)
• China Telecommunications Corporation (China)
• Telus Corporation (U.S.)
• T-Mobile International AG (Germany)
• Verizon Communications, Inc. (U.S.)
• Fusion Telecommunications International, Inc. (U.S.)
• NTT Communications Corporation (Japan)
• CenturyLink, Inc. (U.S.)
• BT Group PLC (U.K.)
• Telstra Corporation Limited (Australia)

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2027

Telecom cloud Market
The Global telecom cloud Market has been segmented on the basis of services, applications, solutions, cloud platform and end users. Services include communication as a service and network as a service. Applications comprises of billing and provisioning and traffic management among others. Solutions include Unified Communication and Collaboration (UCC), Content Delivery Network (CDN), WebRTC and Over-the-Top (OTT) among others. Cloud platform include SaaS, PaaS and IaaS. End users comprises of banking, healthcare, government, transportation and entertainment among others.

Market Research Analysis:
Market Research Future Analysis shows that the billing application of telecom cloud is growing rapidly owing to the increasing need of real time billing, increasing adoption of cloud based services by telecom companies, increase in mobile penetration leading to higher subscriber growth and the reduction in operational and administration cost required for physical billing. However, it is also estimated that the billing application can face challenges such as the rules and regulations imposed by telecom regulatory authorities which might hamper the market growth.

Browse Report @ https://www.marketresearchfuture.com/reports/telecom-cloud-market

Geographically, North America is expected to grow the highest in the telecom cloud market in the forecast period. The market is led by the increased technical knowledge base possessed by the North America industries and adopting cloud based technologies by the telecommunication sector. Europe, on the other hand, has a base of well-developed infrastructure which helps in deployment of high bandwidth network and efficient use of existing big data with telecommunication organizations in the region. Furthermore, Asia pacific region is gaining importance in 3G and 4G technologies in the developing nations namely China and India which is acting as a driving force for telecom cloud market growth in this region. Also, in Asia pacific region telecom cloud providers deploy private cloud solutions, provide interconnects to third-party cloud providers and facilitates easy movement of workloads across various cloud environments which is helping in market growth of telecom cloud in the region.

Intended Audience
• Telecom companies
• Service providers
• Consultancy firms
• Traffic control organization
• System integrator
• Cloud facilitators
• End users

Related Report
Multi Cloud Management Market, by Deployment (Private, Public, Hybrid), by Application (BFSI, Healthcare, Retail, Telecommunication, Life-Science), by Services (Managed services, Task migration, Cloud automation) – Forecast 2022 https://www.marketresearchfuture.com/reports/multi-cloud-management-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Akash Anand
Email: akash.anand@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 524/528, Amanora Chambers, Magarpatta Road, Hadapsar Pune
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/telecom-cloud-market-is-growing-with-a-cagr-of-20-and-reach-usd-29-billion-by-2022/165029

For more information, please visit https://www.marketresearchfuture.com/reports/telecom-cloud-market

Source: MarketersMedia

Release ID: 165029

Stem Cell Research in Cardiology Market 2017 Global Analysis, Opportunities and Forecast To 2021

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Pune, India – January 27, 2017 /MarketersMedia/

Stem Cell Research in Cardiology Industry

Description

Wiseguyreports.Com Adds “Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

Heart disease has assumed great magnitude as an endemic health problem. Cardiology field has seen significant efforts in clinical research in the past few years with the development of new drugs and surgical modalities of therapy as well. However, the mortality rates remain very high. In this context, stem cell applications in cardiology assume great significance since stem cells have been found to be successfully used in tissue regeneration. Heart disease, including myocardial infarction and ischemia, can be treated with the applications of stem cells. This report emphasizes on the market for stem cells in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other).

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/905720-stem-cell-research-in-cardiology-market-research-report

Highlights

Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. The concept of stem cell transplantation to regenerate the myocardium and better the working of the heart has received a great deal of attention in recent times. Small-scale studies in the pre-clinical and clinical stages support the use of stem cells in treating heart disease. However similar such studies must be carried out on a larger-scale to corroborate the findings and prove stem cell therapy as a viable alternative method of treating patients with heart disease. Cells in heart?s muscle are not capable of replacing themselves, and therefore the heart does not return to normal functioning levels once some of these cells are damaged. Other than stem cells therapy and surgery, there are hardly any effective methods available for treating cardiovascular ailments.

This leaves people with congestive heart failure, heart attack, and congenital heart diseases with little hope to improve their quality of life. Though transplanting of heart is an effective technique, donors of heart are few in number. This is where adult stem cell therapy comes in. Adult stem cells are able to coax the existing cells in the heart?s muscles to produce new heart-muscle cells. Adult stem cell therapy for treating heart diseases has been examined in medical tests for efficacy as well as adverse effects. These tests have proved that such stem cell therapy is much better and safer than many existing procedures for treating cardiovascular diseases. This is the reason adult stem cell therapy is gaining importance in cardiac stem cell research.

Exclusive 25 % flat discount (Offer valid till 31st March 2017) @ https://www.wiseguyreports.com/check-discount/905720-stem-cell-research-in-cardiology-market-research-report

Key Players

Athersys, Inc. (USA)

Axordia Ltd. (UK)

Baxter International (USA)

U.S. Stem Cell, Inc. (USA)

Vericel Corporation (USA)

More……….

Why buy this Report

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –

Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data
Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=905720

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Contact Info:
Name: NORAH TRENT
Email: Sales@Wiseguyreports.Com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Pune 411028 , Maharashtra, India
Phone: +1-646-845-9349 / +44 208 133 9349

Source URL: http://marketersmedia.com/stem-cell-research-in-cardiology-market-2017-global-analysis-opportunities-and-forecast-to-2021/165026

For more information, please visit https://www.wiseguyreports.com/sample-request/905720-stem-cell-research-in-cardiology-market-research-report

Source: MarketersMedia

Release ID: 165026

Reactors Market Forecast to 2021 with Key Companies Profile, Supply, Demand, Cost Structure, and SWOT Analysis

ReportsWeb.com added “Global Reactors Market Research Report 2017” to its vast collection of research Database. The report is spread across 123 pages and supported by 10 company leaders.

January 27, 2017 /MarketersMedia/

The Global Reactors Market Research Report 2017 is a professional and in-depth study on the current state of the Reactors Market. This report studies Reactors in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer covering General Electric, Hitachi-GE Nuclear Energy, Mitsubishi Heavy Industries, Larsen and Toubro Industries, Dongfang Electric, Areva, Doosan Heavy Industries
Shanghai Electric Group, Westinghouse and KODA JS.

Request a Sample copy of this research @ http://www.reportsweb.com/inquiry&RW0001566215/sample

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Reactors in these regions, from 2016 to 2021 (forecast), like North America, Europe, China, Japan, Southeast Asia and India. Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I and Type II. Split by application, this report focuses on consumption, market share and growth rate of Reactors in each application, can be divided into Application 1 and Application 2.

View more details about this report @ http://www.reportsweb.com/global-reactors-market-research-report-2017

Few points from Table of Contents

1 Reactors Market Overview

2 Global Reactors Market Competition by Manufacturers

3 Global Reactors Production, Revenue (Value) by Region (2011-2016)

4 Global Reactors Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Reactors Consumption by Regions (2012-2017)
4.2 North America Reactors Production, Consumption, Export, Import (2012-2017)
4.3 Europe Reactors Production, Consumption, Export, Import (2012-2017)
4.4 China Reactors Production, Consumption, Export, Import (2012-2017)
4.5 Japan Reactors Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Reactors Production, Consumption, Export, Import (2012-2017)
4.7 India Reactors Production, Consumption, Export, Import (2012-2017)

5 Global Reactors Production, Revenue (Value), Price Trend by Type
5.1 Global Reactors Production and Market Share by Type (2012-2017)
5.2 Global Reactors Revenue and Market Share by Type (2012-2017)
5.3 Global Reactors Price by Type (2012-2017)
5.4 Global Reactors Production Growth by Type (2012-2017)

6 Global Reactors Market Analysis by Application
6.1 Global Reactors Consumption and Market Share by Application (2012-2017)
6.2 Global Reactors Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Reactors Manufacturers Profiles/Analysis
7.1 General Electric
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Reactors Product Type, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 General Electric Reactors Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Hitachi-GE Nuclear Energy
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Reactors Product Type, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Hitachi-GE Nuclear Energy Reactors Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Mitsubishi Heavy Industries
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Reactors Product Type, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Mitsubishi Heavy Industries Reactors Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview

8 Reactors Manufacturing Cost Analysis

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

11 Market Effect Factors Analysis

12 Global Reactors Market Forecast (2016-2021)

13 Research Findings and Conclusion

Buy a copy of complete 123 pages report @ http://www.reportsweb.com/buy&RW0001566215/buy/2900

Contact Info:
Name: Sameer Joshi
Email: sales@reportsweb.com
Organization: ReportsWeb
Address: Pune, India.
Phone: +1-646-491-9876

Source URL: http://marketersmedia.com/reactors-market-forecast-to-2021-with-key-companies-profile-supply-demand-cost-structure-and-swot-analysis/165002

For more information, please visit http://www.reportsweb.com/global-reactors-market-research-report-2017

Source: MarketersMedia

Release ID: 165002

Tissue Sealants Market 2017 Global Analysis, Opportunities and Forecast To 2021

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Pune, India – January 27, 2017 /MarketersMedia/

Tissue Sealants Industry

Description

Wiseguyreports.Com Adds “Tissue Sealants -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

Tissue sealants Market research report provides an in depth analysis of the global Tissue Sealants market including various sources of Sealants and the various applications. The Sources of Tissue Sealants covered include Homologous Sealants, Synthetic Sealants and Autologous Sealants. The applications of Tissue Sealants covered include Odontology, Cardiology, Neurology, Orthopedics and Other (such as Urology, Hepatic, and Dermatology etc.).

The study includes estimations and predictions for the total global Tissue Sealants market size and also key regional markets including North America, Europe, Asia-Pacific, Latin America and Rest of World. Historic, current and future markets are illustrated graphically (125 exhibits) for the analysis period 2010-2022. More than 160 companies are covered while business profiles of 25 major companies are discussed in the report. The report serves as a guide to global Tissue Sealants market. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions also covered in the report. Compilation of Worldwide Patents and Research related to Tissue Sealants is also provided.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/905721-tissue-sealants-market-research-report

Highlights

The use of hemostats and sealants during surgeries is both cost effective and time saving. The application of these substances to the wounds helps the patient to recover faster than the normal methods of suturing and stapling, thus saving both money and time. The whole surgical process becomes safer and faster. Mainly, these products are applied to the external wounds. The application and the working of these products in treating the internal injuries have to be explored extensively. Application of cyanoacrylate glues for closure of surgical wounds is approved worldwide. The usual process of closing a small bleeding trauma laceration by suturing includes use of local anesthesia, antibiotic cream and suture removal kit. In contrast, cyanoacrylate products can be applied without anesthetic and without sutures. There is no need for a removal as cyanoacrylate sloughs off the skin surface. Experiments proved that cyanoacrylate products have an anti?microbial property which gave the product an approval by the FDA. This property also aids in the reduction of the costs to approximately 30% of using sutures.

The cost further reduces to 5% of suture cost on inclusion of labor and time to the application of product. Many of the critical surgeries take longer time as they are to be performed carefully avoiding heavy bleeding during the surgery. Application of hemostats considerably reduces the time and in turn the cost (estimated to be $2000 to $10000 per hour) of the surgery as the operation can be done faster than the expected time because of less hemorrhage during surgery. Based upon the surgical process hemostats save five to two hours of surgery time. Use of sealants is not only a cost effective but also an attractive health economic attribute. This was proved in cases of air leaks occurring after lung resection. Use of normal sutures and staples sometimes result in air leaks in lung resection patients. Due to this, the patient has to stay for longer periods of time in the hospital for nearly a month after surgery in the intensive care unit and in some rare cases has to endure another surgery. Use of sealants completely eliminates air leaks and thus the extra burden in the form of mental stress, time and expenses on the patient can be reduced effectively. Neurological and spine injuries sometimes result in leakage of cerebrospinal fluid due to infections like meningitis, severe headaches and other miscellaneous reasons. In order to avoid the cerebrospinal fluid leaks, the normal process is to close the dura which is time consuming. Application of proper sealants by efficient surgeons can tackle the problem of cerebrospinal fluid leakage.

Scope for maximum tissue sealant applications (licensed indications) exist in dental, cardiac, pulmonary and vascular surgeries. There is an ascending perception in the use of tissue sealants in hepatic surgery. The need for sealants in burn applications are set to multiply, while more investigations are being done in orthopedic indications. The current pharmaco-economic data is efficient in convincing the medical practitioners about versatility, superiority and cost advantage of tissue sealants over challenging alternatives. The problem of replacement caused due to unclear demarcation between various wound care products can be solved by developing the comparative benefits of tissue sealants over other closure devices

Exclusive 25 % flat discount (Offer valid till 31st March 2017) @ https://www.wiseguyreports.com/check-discount/905721-tissue-sealants-market-research-report

Key Players

3M Company (USA)

Abbott Laboratories (USA)

Advanced Medical Solutions Group plc (UK)

B. Braun Melsungen AG (Germany)

Baxter International, Inc. (USA)

C. R. Bard, Inc. (USA)

Cesca Therapeutics, Inc. (USA)

Cohera Medical, Inc. (USA)

CryoLife, Inc. (USA)

CSIRO (Australia)

CSL Behring (USA)

Ethicon, Inc. (USA)

GluStitch, Inc. (USA)

KAKETSUKEN (Japan)

Koninklijke DSM N.V (The Netherlands)

LABORATOIRES URGO (France)

Medicines Co. (The) (USA)

Medtronic (USA)

Olympus Terumo Biomaterials Corporation (Japan)

Pfizer, Inc. (USA)

Shanghai Pine & Power Biotech Co., Ltd. (China)

Takeda Pharmaceuticals International GmbH (Switzerland)

Tissuemed Ltd. (UK)

Vivostat A/S (Denmark)

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=905721

Why buy this Report

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –

Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Contact Info:
Name: NORAH TRENT
Email: Sales@Wiseguyreports.Com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Pune 411028 , Maharashtra, India
Phone: +1-646-845-9349 / +44 208 133 9349

Source URL: http://marketersmedia.com/tissue-sealants-market-2017-global-analysis-opportunities-and-forecast-to-2021/165036

For more information, please visit https://www.wiseguyreports.com/sample-request/905721-tissue-sealants-market-research-report

Source: MarketersMedia

Release ID: 165036